On Monday, Prana Biotechnology Limited (ADR) (NASDAQ:PRAN)’s shares inclined 6.57% to $1.46.
Prana Biotechnology Limited (ADR) (PRAN) has declared that the European Commission has approved orphan designation for PBT2 for the treatment of Huntington’s disease, stating that Prana has shown that PBT2 might be of noteworthy benefit for patients with Huntington’s disease.
The approval was based on the recommendation of a positive opinion from the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP). The COMP assessed the scientific documentation for PBT2 against the key criteria for orphan designation. The criteria require that PBT2 be intended for the treatment, prevention or diagnosis of a disease that is life-threatening or chronically debilitating; have a prevalence in the EU not more than five in 10,000, and no satisfactory method of diagnosis, prevention or treatment of the condition concerned, or, if such a method exists, the medicine must be of noteworthy benefit to those affected by the condition.
Prana Biotechnology Limited develops therapies for the treatment of neurodegenerative diseases in Australia. The company focuses on the Alzheimer’s and Huntington’s diseases, in addition to other age-related degeneration disorders. Its lead drug candidate comprises PBT2 for the treatment of Alzheimer’s and Huntington’s diseases.
Darling Ingredients Inc (NYSE:DAR)’s shares dropped -0.76% to $15.58.
Darling Ingredients Inc (DAR) a wholly-owned indirect partner of the Company incorporated under the laws of The Netherlands, has priced a private offering (the “Notes Offering”) of €515 million in aggregate principal amount of its 4.75% unsecured senior notes due 2022 (the “Notes”). The Notes Offering is predictable to close on or about June 3, 2015, subject to customary closing conditions.
The gross proceeds of the Notes Offering are predictable to be used to refinance the outstanding borrowings under the euro term loan B under the Company’s Senior Secured Credit Facilities, to pay the initial purchasers’ commission, to pay fees and expenses related to the Notes Offering and to use any remaining proceeds for general corporate purposes. The Notes will be offered inside the United States to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to non-U.S. persons in reliance on Regulation S under the Securities Act. The Notes will not be registered under the Securities Act or any state securities laws and, unless so registered, may not be offered or sold in the United States except following an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws.
Darling Ingredients Inc. develops, produces, and sells natural ingredients from edible and inedible bio-nutrients worldwide. It operates in three segments: Feed Ingredients, Food Ingredients, and Fuel Ingredients. The company offers a range of ingredients and customized specialty solutions for customers in the pharmaceutical, food, pet food, feed, technical, fuel, bioenergy, and fertilizer industries.
At the end of Monday’s trade, Alaska Air Group, Inc. (NYSE:ALK)‘s shares surged 2.26% to $66.10.
Alaska Air Group, Inc. (ALK) CEO Brad Tilden declared recently during a keynote speech at the JumpStart Air Service Development conference that Alaska will add new flying between Portland, Oregon, and Austin, Texas, and Eugene, Oregon, and San Jose, California, starting Nov. 5.
The Portland-Austin flight will be operated for Alaska by SkyWest Airlines, using new 76-seat Embraer 175 jets. The E175 jet features 12 seats in first class and 64 in coach, and with cabin dimensions on par with a 737. Onboard amenities comprise Wi-Fi Internet access, streaming inflight entertainment and 110 volt power in every first class seat. Food and beverage will comprise hot meals and picnic packs for purchase, in addition to Northwest microbrews and wine.
Alaska Air Group, Inc., through its auxiliaries, provides passengers and cargo air transportation services primarily in the United States. The company operates through Alaska Mainline and Alaska Regional segments. It serves about 100 cities in Alaska, the Lower 48, Hawaii, Canada, and Mexico. As of December 31, 2014, the companys fleet compriseed of 137 Boeing 737 jet aircraft; and 51 Bombardier Q400 turboprop aircraft. The company was founded in 1932 and is based in Seattle, Washington.
Mitsubishi UFJ Financial Group Inc (ADR) (NYSE:MTU), ended its Monday’s trading session with 1.90% gain, and closed at $7.51.
Mitsubishi UFJ Financial Group Inc (ADR) (MTU) declared the opening of a Bank of Tokyo-Mitsubishi UFJ (Canada) - BTMU Canada - office in Calgary.
BTMU Canada is a wholly owned partner of The Bank of Tokyo-Mitsubishi UFJ, Ltd. and is the premier Asia-based global bank in Canada. Headquartered in Toronto and with offices in Vancouver and Montreal, the bank has added a fourth location in Canada with the opening of the new Calgary office. The office is located at 440 Second Avenue in Calgary.
Mitsubishi UFJ Financial Group, Inc., through its auxiliaries, provides financial services in Japan and internationally. Its Integrated Retail Banking Business Group segment offers a range of banking products and services, counting financial consulting services; deposit products comprising non-interest-bearing deposit accounts; asset administration and administration services; trust products; and other investment products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
